We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Berdeja - Phase 1/2 Study of Oral MLN9708, A Novel, Investigational Proteasome Inhibitor, in Combination with Lenalidomide and Dexamethasone in Patients with Previously Untreated Multiple Myeloma (MM)
Jesus G. Berdeja, MD
Sarah Cannon Research Institute
Nashville, Tennessee, USA
12.01.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles